|
- Expanded treatment and visualization capabilities within posterior care workflows: ICGA for ZEISS CLARUS 700 offers FA + ICG simultaneous capture to help support clinical assessment and streamline the diagnostic process; ZEISS VISULAS green, now available with ZEISS SLT, offers dependable retinal photocoagulation.
- Ergonomic diagnostic tools support efficient workflows and streamlined examination steps: ZEISS VISUREF 600 wavefront refraction consolidates multiple assessments to support efficiency and reliable results; ZEISS VISUCORE 500 all-in-one combined refraction unit helps save space and increase efficiency.
- Enhanced therapeutic care improves ZEISS Cataract Workflow: ZEISS VISULAS yag new-generation, therapeutic laser provides anterior segment photodisruption.
- Consistent clinical review with new digital data management offerings: ZEISS FORUM subscription packages offer an agile, integrated solution that grows with the clinic.
JENA, Germany and TORONTO, March 24, 2026 /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, announced today the expansion of clinical workflows for ophthalmology and optometry in Canada, including advanced diagnostic equipment, new-generation laser treatment devices, and efficient digital workflow tools and enhancements. ZEISS innovations will be showcased at the Ontario Association of Optometrists conference from March 27 – 29, in Ottawa, ON, and at the Canadian Ophthalmological Society conference from June 18 – 21, in Montréal, QC, Canada.
"ZEISS is proud to expand access to advanced therapeutic lasers, diagnostic technologies, and digital workflow solutions in Canada. These innovations help enhance patient care across our clinical workflows and reflect our commitment to supporting eye care professionals with integrated solutions which offer tools that support them in making informed care decisions, improving practice efficiency, and delivering better outcomes for patients across the country," says Bryan Rossi, President of ZEISS Canada.
Expanded treatment and visualization capabilities within posterior care workflows
ZEISS has added diagnostic and therapeutic features for use within established clinical workflows. Supporting clinical assessment with advanced imaging and workflow tools, the CLARUS® 700 with ICGA provides high-resolution early-phase to late-phase ultra-widefield imaging for both retina and glaucoma care. New features include standalone ICG, simultaneous FA-ICG capture, and an added movie mode for all angiography modalities: standalone FA, standalone ICG, and simultaneous FA-ICG. Additionally, this year marks the 100-year anniversary of advancements in ZEISS fundus imaging. In 1926, ZEISS and Johan Nordenson released the first commercially available fundus camera, laying the foundation for a century of innovation in ocular imaging technology.
Now available with ZEISS SLT as a first-line treatment of primary open-angle glaucoma, the VISULAS® green from ZEISS delivers dependable retinal photocoagulation to support procedures for diabetic retinopathy, retinal tears, and other chorioretinal indications. Helping clinicians work quickly and comfortably, the ZEISS VISULAS green allows clinicians to monitor parameters such as laser power, pulse duration, and spot size without taking their eyes off the patient or the treatment area. While viewing parameters in the eyepiece, the ZEISS VISULAS green has a TouchControl center switch to adjust laser energy or other settings simultaneously. Additionally, the therapeutic laser automatically generates treatment summaries that can be exported directly to the ZEISS FORUM data management system for a paperless record. The ZEISS VISULAS green is compatible with digital workflow tools such as ZEISS FORUM.
Ergonomic diagnostic tools support efficient workflows and streamlined examination steps
Now available in Canada, the ZEISS VISUREF 600 and ZEISS VISUCORE 500 refraction devices support a streamlined workflow for reliable refraction diagnoses in optometry clinics. The VISUREF® 600 from ZEISS consolidates multiple assessments into one to offer refraction workflow tools from fast, reliable pretests to data-driven subjective refraction—delivering higher diagnostic confidence, more consistent prescriptions, and a cohesive, step wise workflow experience from first measurement to tailored lens consultation. Intuitive ergonomics and scalable configurations help standardize protocols across teams and boost throughput, while modern connectivity helps elevate patient satisfaction and trust in clinical outcomes.
Additionally, the ZEISS VISUCORE 500 provides an all-in-one combined refraction unit that delivers space-saving refraction with a footprint of under 0.8 m2 solution to help eye care professionals streamline their workflow, standardize testing, and increase patient comfort and workflow convenience —from objective measurements through guided subjective refraction. By consolidating key steps and enabling seamless data flow to practice software, it's designed to support efficient workflows and streamlined examination steps. The device offers tools that support clinicians in making informed care decisions, more efficient use of clinic space and staff, and a cohesive, step wise workflow experience for clinicians and patients.
Enhancing anterior patient care within the ZEISS Cataract Workflow
Expanding ophthalmologists' treatment capabilities within the cataract workflow in Canada, ZEISS now offers the VISULAS® yag from ZEISS new generation therapeutic laser enabling intuitive ergonomics and streamlined workflows for confident anterior segment photodisruption. The system empowers clinicians with versatile, laser-based treatment capabilities, optimized workflows, and evidence-backed performance that aligns with ZEISS's commitment to patient-centric innovation.
The ZEISS VISULAS yag delivers precise laser photodisruption for posterior capsulotomy and iridotomy, with a compact, application-based workstation that offers intuitive focus-shift targeting and selectable aiming beams to streamline clinical workflows— designed with patient comfort and workflow convenience in mind. The ZEISS VISULAS yag is compatible with digital workflow tools such as ZEISS FORUM.
Streamlined digital workflow supports consistent clinical review
Now available as a subscription package in Canada, FORUM® from ZEISS helps clinics streamline their workflow, centralize ophthalmic data to support consistent clinical review, and simplify a clinic's digital environment. It enables a fully electronic workflow where clinicians can send patient demographics automatically to the instruments for a paperless workflow. It also facilitates clinical case visualization by preparing ophthalmic data and images to better support patient care. Additionally, it integrates conveniently into a clinic's existing IT infrastructure using established standards as well as customized tools, ensuring patient record consistency.
With the ZEISS FORUM subscription package, clinics utilize the company's leading data management system to receive an agile, integrated solution that grows with the clinic. With the subscription package, clinics benefit from unlimited device licenses and connections including non-ZEISS devices, lower upfront costs with predictable payments, access to the latest features and improvements, and ongoing service and expert support.
"ZEISS FORUM Glaucoma Workspace has significantly strengthened our clinical workflow, enabling faster, more confident decisions in both initiating and managing glaucoma. Its ability to centralize diagnostic data enhances clarity and collaboration within our team," says Dr. Megan Sear, Licensed Optician at Bay Vision Care, Ontario, Canada.
For more information about product availability in Canada, please visit the ZEISS Medical Technology Canada website or speak to your local ZEISS representative.
Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.
www.zeiss.com/newsroom
Company Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).
The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
- Expanded treatment and visualization capabilities within posterior care workflows: ICGA for ZEISS CLARUS 700 offers FA + ICG simultaneous capture to help support clinical assessment and streamline the diagnostic process; ZEISS VISULAS green, now available with ZEISS SLT, offers dependable retinal photocoagulation.
- Ergonomic diagnostic tools support efficient workflows and streamlined examination steps: ZEISS VISUREF 600 wavefront refraction consolidates multiple assessments to support efficiency and reliable results; ZEISS VISUCORE 500 all-in-one combined refraction unit helps save space and increase efficiency.
- Enhanced therapeutic care improves ZEISS Cataract Workflow: ZEISS VISULAS yag new-generation, therapeutic laser provides anterior segment photodisruption.
- Consistent clinical review with new digital data management offerings: ZEISS FORUM subscription packages offer an agile, integrated solution that grows with the clinic.
Click to Gallery
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
JENA, Germany and TORONTO, March 24, 2026 /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, announced today the expansion of clinical workflows for ophthalmology and optometry in Canada, including advanced diagnostic equipment, new-generation laser treatment devices, and efficient digital workflow tools and enhancements. ZEISS innovations will be showcased at the Ontario Association of Optometrists conference from March 27 – 29, in Ottawa, ON, and at the Canadian Ophthalmological Society conference from June 18 – 21, in Montréal, QC, Canada.
"ZEISS is proud to expand access to advanced therapeutic lasers, diagnostic technologies, and digital workflow solutions in Canada. These innovations help enhance patient care across our clinical workflows and reflect our commitment to supporting eye care professionals with integrated solutions which offer tools that support them in making informed care decisions, improving practice efficiency, and delivering better outcomes for patients across the country," says Bryan Rossi, President of ZEISS Canada.
Expanded treatment and visualization capabilities within posterior care workflows
ZEISS has added diagnostic and therapeutic features for use within established clinical workflows. Supporting clinical assessment with advanced imaging and workflow tools, the CLARUS® 700 with ICGA provides high-resolution early-phase to late-phase ultra-widefield imaging for both retina and glaucoma care. New features include standalone ICG, simultaneous FA-ICG capture, and an added movie mode for all angiography modalities: standalone FA, standalone ICG, and simultaneous FA-ICG. Additionally, this year marks the 100-year anniversary of advancements in ZEISS fundus imaging. In 1926, ZEISS and Johan Nordenson released the first commercially available fundus camera, laying the foundation for a century of innovation in ocular imaging technology.
Now available with ZEISS SLT as a first-line treatment of primary open-angle glaucoma, the VISULAS® green from ZEISS delivers dependable retinal photocoagulation to support procedures for diabetic retinopathy, retinal tears, and other chorioretinal indications. Helping clinicians work quickly and comfortably, the ZEISS VISULAS green allows clinicians to monitor parameters such as laser power, pulse duration, and spot size without taking their eyes off the patient or the treatment area. While viewing parameters in the eyepiece, the ZEISS VISULAS green has a TouchControl center switch to adjust laser energy or other settings simultaneously. Additionally, the therapeutic laser automatically generates treatment summaries that can be exported directly to the ZEISS FORUM data management system for a paperless record. The ZEISS VISULAS green is compatible with digital workflow tools such as ZEISS FORUM.
Ergonomic diagnostic tools support efficient workflows and streamlined examination steps
Now available in Canada, the ZEISS VISUREF 600 and ZEISS VISUCORE 500 refraction devices support a streamlined workflow for reliable refraction diagnoses in optometry clinics. The VISUREF® 600 from ZEISS consolidates multiple assessments into one to offer refraction workflow tools from fast, reliable pretests to data-driven subjective refraction—delivering higher diagnostic confidence, more consistent prescriptions, and a cohesive, step wise workflow experience from first measurement to tailored lens consultation. Intuitive ergonomics and scalable configurations help standardize protocols across teams and boost throughput, while modern connectivity helps elevate patient satisfaction and trust in clinical outcomes.
Additionally, the ZEISS VISUCORE 500 provides an all-in-one combined refraction unit that delivers space-saving refraction with a footprint of under 0.8 m2 solution to help eye care professionals streamline their workflow, standardize testing, and increase patient comfort and workflow convenience —from objective measurements through guided subjective refraction. By consolidating key steps and enabling seamless data flow to practice software, it's designed to support efficient workflows and streamlined examination steps. The device offers tools that support clinicians in making informed care decisions, more efficient use of clinic space and staff, and a cohesive, step wise workflow experience for clinicians and patients.
Enhancing anterior patient care within the ZEISS Cataract Workflow
Expanding ophthalmologists' treatment capabilities within the cataract workflow in Canada, ZEISS now offers the VISULAS® yag from ZEISS new generation therapeutic laser enabling intuitive ergonomics and streamlined workflows for confident anterior segment photodisruption. The system empowers clinicians with versatile, laser-based treatment capabilities, optimized workflows, and evidence-backed performance that aligns with ZEISS's commitment to patient-centric innovation.
The ZEISS VISULAS yag delivers precise laser photodisruption for posterior capsulotomy and iridotomy, with a compact, application-based workstation that offers intuitive focus-shift targeting and selectable aiming beams to streamline clinical workflows— designed with patient comfort and workflow convenience in mind. The ZEISS VISULAS yag is compatible with digital workflow tools such as ZEISS FORUM.
Streamlined digital workflow supports consistent clinical review
Now available as a subscription package in Canada, FORUM® from ZEISS helps clinics streamline their workflow, centralize ophthalmic data to support consistent clinical review, and simplify a clinic's digital environment. It enables a fully electronic workflow where clinicians can send patient demographics automatically to the instruments for a paperless workflow. It also facilitates clinical case visualization by preparing ophthalmic data and images to better support patient care. Additionally, it integrates conveniently into a clinic's existing IT infrastructure using established standards as well as customized tools, ensuring patient record consistency.
With the ZEISS FORUM subscription package, clinics utilize the company's leading data management system to receive an agile, integrated solution that grows with the clinic. With the subscription package, clinics benefit from unlimited device licenses and connections including non-ZEISS devices, lower upfront costs with predictable payments, access to the latest features and improvements, and ongoing service and expert support.
"ZEISS FORUM Glaucoma Workspace has significantly strengthened our clinical workflow, enabling faster, more confident decisions in both initiating and managing glaucoma. Its ability to centralize diagnostic data enhances clarity and collaboration within our team," says Dr. Megan Sear, Licensed Optician at Bay Vision Care, Ontario, Canada.
For more information about product availability in Canada, please visit the ZEISS Medical Technology Canada website or speak to your local ZEISS representative.
Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.
www.zeiss.com/newsroom
Company Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).
The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
|
- Resumes services to Fukuoka, Japan from September 2026 after nearly two decades
- Expands China footprint with new direct services to Shenzhen and Changsha, commencing July 2026
- "MAG Arena" showcases Asia's Largest Airline Pavilion at MATTA Fair 2026, featuring the region's premier sports partnership activation by an airline
- Increases frequencies across ASEAN, South Asia, Australia and New Zealand and Europe to further strengthen global connectivity
SINGAPORE, April 5, 2026 /PRNewswire/ -- Malaysia Airlines is significantly expanding its East Asia footprint with the return of direct flights to Fukuoka, Japan, and the launch of new services to Shenzhen and Changsha, China. Commencing between July and September 2026, these additions bring the airline's China network to nine key gateways and reinforce its commitment to providing greater travel flexibility across the region.
As part of this expansion, the airline will introduce new services between Kuala Lumpur and Shenzhen (SZX) and Changsha (CSX) in China, alongside the resumption of services to Fukuoka (FUK) in Japan, which the airline last operated in September 2006. With the launch of these destinations, Malaysia Airlines consolidates its presence across a total of nine strategic destinations in China, including Beijing (PKX), Shanghai (PVG), Guangzhou (CAN), Xiamen (XMN), Hong Kong (HKG), Taipei (TPE), and Chengdu Tianfu (TFU). Ticket sales for the new services commence today, supporting the growing travel demand and strengthening connectivity between Malaysia and these high-growth regional hubs.
Captain Nasaruddin A. Bakar, President and Group Chief Executive Officer of Malaysia Aviation Group (MAG), said, "This expansion reflects our strategic focus on scaling our presence in key growth markets across East Asia while cementing Kuala Lumpur's position as a key strategic gateway. Both Shenzhen and Changsha align perfectly with our network strategy, driven by robust demand across both business and leisure segments. The return to Fukuoka further enhances our network depth. As the only carrier operating direct flights on this route, we are proud to offer passengers a seamless non-stop experience that eliminates the need for transit. These developments demonstrate our ongoing commitment to optimising our network and delivering a more integrated travel experience for our customers."
Beyond the East Asia expansion, Malaysia Airlines is increasing flight frequencies across key routes namely Brisbane, Australia; Manila, Philippines and Colombo, Sri Lanka to meet rising demand while supporting growing tourism and trade links. In addition, the airline will operate ad-hoc Kuala Lumpur–London flights on 18 and 22 April 2026 to accommodate passengers affected by recent Middle Eastern carrier disruptions.
As the returning Official Airline Partner and Premier Sponsor of MATTA Fair 2026, MAG unveiled its most ambitious presence yet with the launch of the MAG Arena, recognised by both the Asia Records and ASEAN Records as Asia's Largest Airline Trade Pavilion at a consumer travel fair.
Spanning approximately 46,000 square feet, nearly three times the scale of its participation in September last year, the expanded pavilion transforms the MATTA Fair experience into a fully immersive destination showcasing curated experiences and next-generation travel technology that brings journeys to life before travellers even board the aircraft. Visitors will be able to explore destinations, discover travel innovations and experience the warmth of Malaysian Hospitality through interactive engagements designed to inspire their next journey.
In addition, the pavilion will host Asia's largest sports partnership activation by an airline, celebrating Malaysia Airlines' collaborations with global clubs like Manchester United and national sporting icons Datuk Azizulhasni Awang and others. The dedicated sports experience zone will allow football fans and travellers to engage with legends and their favourite sports personalities — reinforcing how sport and travel connect people across borders and generations.
Through the expansion of its network and increased flight frequencies, the airline continues to strengthen Kuala Lumpur's position as a key gateway to Asia and beyond, while supporting Malaysia's tourism ambitions under Visit Malaysia 2026 and advancing its journey towards becoming one of the world's Top 10 global airlines by 2030.
-ENDS-
New Routes
| Airline | Route | Frequency | Date Open for Sale | Inaugural Flight |
| Malaysia Airlines | Kuala Lumpur – Shenzhen (SZX) | 7x weekly (Mon-Sun) | 3 April 2026 | 1 July 2026 |
| Kuala Lumpur – Changsha (CSX) | 7x weekly (Mon-Sun) | 3 April 2026 | 8 July 2026 |
| Kuala Lumpur -Fukuoka (FUK) | 5x weekly (Mon, Wed, Fri, Sat, Sun) | 3 April 2026 | 2 Sept 2026 |
Malaysia Airlines' Additional Frequencies
| Region | Route | Frequency (Before Increase) | Frequency
(After Increase) | Effective Date |
| Europe | KUL/London (LHR) | 14x weekly | 16x weekly | 18 & 22 Apr 2026 |
| Australia and New Zealand | KUL/Brisbane (BNE) vv | 5x weekly | 6x weekly 7x weekly | 16 Aug 2026 25 Oct 2026 |
| ASEAN | KUL/Manila (MNL) vv | 21x weekly | 28x weekly | 1 Jul 2026 |
| South Asia | KUL/Colombo (CMB) vv | 7x weekly | 8x weekly 9x weekly 10x weekly | 3 Apr 2026 3 May 2026 20 May 2026 |
About Malaysia Aviation Group
Malaysia Aviation Group (MAG) is a global aviation organisation comprising three core business portfolios: Airline Business, Loyalty & Travel Services, and Aviation Services.
The Airline Business portfolio serves global, domestic, and segmented markets through Malaysia Airlines – the national carrier; Firefly – the regional airline focused on connecting communities across Malaysia and ASEAN; and Amal by Malaysia Airlines – the leading one-stop pilgrimage travel solutions centre.
The Aviation Services portfolio offers a full suite of capabilities, comprising MAB Engineering, the maintenance, repair and overhaul services provider; MASkargo, the cargo and logistics solutions provider; AeroDarat Services, the ground handling services provider; MAG Culinary Solutions, overseeing all F&B-related strategies, operations and services across MAG; and MAB Academy, the centre of excellence for aviation and hospitality training.
The Loyalty & Travel Services portfolio delivers end-to-end travel solutions and loyalty programmes, strengthening MAG's core expertise in airline and aviation services. It includes Journify – an integrated digital platform offering travel and lifestyle experiences; Enrich – Malaysia Airlines' award-winning travel and lifestyle loyalty programme; and MHholidays – the Group's dedicated flight and hotel package platform.
With its clear business portfolios, MAG is committed to realising its vision of becoming Asia's Leading Travel and Aviation Services Group by delivering exceptional customer experiences, nurturing a culture that empowers its people, and ensuring sustainable, profitable growth.
For more information, visit www.malaysiaaviationgroup.com.my
Issued by Group Communications, Malaysia Aviation Group.
- Resumes services to Fukuoka, Japan from September 2026 after nearly two decades
- Expands China footprint with new direct services to Shenzhen and Changsha, commencing July 2026
- "MAG Arena" showcases Asia's Largest Airline Pavilion at MATTA Fair 2026, featuring the region's premier sports partnership activation by an airline
- Increases frequencies across ASEAN, South Asia, Australia and New Zealand and Europe to further strengthen global connectivity
SINGAPORE, April 5, 2026 /PRNewswire/ -- Malaysia Airlines is significantly expanding its East Asia footprint with the return of direct flights to Fukuoka, Japan, and the launch of new services to Shenzhen and Changsha, China. Commencing between July and September 2026, these additions bring the airline's China network to nine key gateways and reinforce its commitment to providing greater travel flexibility across the region.
As part of this expansion, the airline will introduce new services between Kuala Lumpur and Shenzhen (SZX) and Changsha (CSX) in China, alongside the resumption of services to Fukuoka (FUK) in Japan, which the airline last operated in September 2006. With the launch of these destinations, Malaysia Airlines consolidates its presence across a total of nine strategic destinations in China, including Beijing (PKX), Shanghai (PVG), Guangzhou (CAN), Xiamen (XMN), Hong Kong (HKG), Taipei (TPE), and Chengdu Tianfu (TFU). Ticket sales for the new services commence today, supporting the growing travel demand and strengthening connectivity between Malaysia and these high-growth regional hubs.
Captain Nasaruddin A. Bakar, President and Group Chief Executive Officer of Malaysia Aviation Group (MAG), said, "This expansion reflects our strategic focus on scaling our presence in key growth markets across East Asia while cementing Kuala Lumpur's position as a key strategic gateway. Both Shenzhen and Changsha align perfectly with our network strategy, driven by robust demand across both business and leisure segments. The return to Fukuoka further enhances our network depth. As the only carrier operating direct flights on this route, we are proud to offer passengers a seamless non-stop experience that eliminates the need for transit. These developments demonstrate our ongoing commitment to optimising our network and delivering a more integrated travel experience for our customers."
Beyond the East Asia expansion, Malaysia Airlines is increasing flight frequencies across key routes namely Brisbane, Australia; Manila, Philippines and Colombo, Sri Lanka to meet rising demand while supporting growing tourism and trade links. In addition, the airline will operate ad-hoc Kuala Lumpur–London flights on 18 and 22 April 2026 to accommodate passengers affected by recent Middle Eastern carrier disruptions.
As the returning Official Airline Partner and Premier Sponsor of MATTA Fair 2026, MAG unveiled its most ambitious presence yet with the launch of the MAG Arena, recognised by both the Asia Records and ASEAN Records as Asia's Largest Airline Trade Pavilion at a consumer travel fair.
Spanning approximately 46,000 square feet, nearly three times the scale of its participation in September last year, the expanded pavilion transforms the MATTA Fair experience into a fully immersive destination showcasing curated experiences and next-generation travel technology that brings journeys to life before travellers even board the aircraft. Visitors will be able to explore destinations, discover travel innovations and experience the warmth of Malaysian Hospitality through interactive engagements designed to inspire their next journey.
In addition, the pavilion will host Asia's largest sports partnership activation by an airline, celebrating Malaysia Airlines' collaborations with global clubs like Manchester United and national sporting icons Datuk Azizulhasni Awang and others. The dedicated sports experience zone will allow football fans and travellers to engage with legends and their favourite sports personalities — reinforcing how sport and travel connect people across borders and generations.
Through the expansion of its network and increased flight frequencies, the airline continues to strengthen Kuala Lumpur's position as a key gateway to Asia and beyond, while supporting Malaysia's tourism ambitions under Visit Malaysia 2026 and advancing its journey towards becoming one of the world's Top 10 global airlines by 2030.
-ENDS-
New Routes
Airline
Route
Frequency
Date Open for Sale
Inaugural Flight
Malaysia Airlines
Kuala Lumpur –
Shenzhen (SZX)
7x weekly
(Mon-Sun)
3 April 2026
1 July 2026
Kuala Lumpur –
Changsha (CSX)
7x weekly
(Mon-Sun)
3 April 2026
8 July 2026
Kuala Lumpur -Fukuoka (FUK)
5x weekly
(Mon, Wed, Fri, Sat, Sun)
3 April 2026
2 Sept 2026
Malaysia Airlines' Additional Frequencies
| Region | Route | Frequency (Before Increase) | Frequency
(After Increase) | Effective Date |
| Europe | KUL/London (LHR) | 14x weekly | 16x weekly | 18 & 22 Apr 2026 |
| Australia and New Zealand | KUL/Brisbane (BNE) vv | 5x weekly | 6x weekly 7x weekly | 16 Aug 2026 25 Oct 2026 |
| ASEAN | KUL/Manila (MNL) vv | 21x weekly | 28x weekly | 1 Jul 2026 |
| South Asia | KUL/Colombo (CMB) vv | 7x weekly | 8x weekly 9x weekly 10x weekly | 3 Apr 2026 3 May 2026 20 May 2026 |
Region
Route
Frequency
(Before Increase)
Frequency
(After Increase)
Effective Date
Europe
KUL/London (LHR)
14x weekly
16x weekly
18 & 22 Apr 2026
Australia and New Zealand
KUL/Brisbane (BNE) vv
5x weekly
6x weekly 7x weekly
16 Aug 2026
25 Oct 2026
ASEAN
KUL/Manila
(MNL) vv
21x weekly
28x weekly
1 Jul 2026
South Asia
KUL/Colombo (CMB) vv
7x weekly
8x weekly
9x weekly 10x weekly
3 Apr 2026
3 May 2026
20 May 2026
About Malaysia Aviation Group
Malaysia Aviation Group (MAG) is a global aviation organisation comprising three core business portfolios: Airline Business, Loyalty & Travel Services, and Aviation Services.
The Airline Business portfolio serves global, domestic, and segmented markets through Malaysia Airlines – the national carrier; Firefly – the regional airline focused on connecting communities across Malaysia and ASEAN; and Amal by Malaysia Airlines – the leading one-stop pilgrimage travel solutions centre.
The Aviation Services portfolio offers a full suite of capabilities, comprising MAB Engineering, the maintenance, repair and overhaul services provider; MASkargo, the cargo and logistics solutions provider; AeroDarat Services, the ground handling services provider; MAG Culinary Solutions, overseeing all F&B-related strategies, operations and services across MAG; and MAB Academy, the centre of excellence for aviation and hospitality training.
The Loyalty & Travel Services portfolio delivers end-to-end travel solutions and loyalty programmes, strengthening MAG's core expertise in airline and aviation services. It includes Journify – an integrated digital platform offering travel and lifestyle experiences; Enrich – Malaysia Airlines' award-winning travel and lifestyle loyalty programme; and MHholidays – the Group's dedicated flight and hotel package platform.
With its clear business portfolios, MAG is committed to realising its vision of becoming Asia's Leading Travel and Aviation Services Group by delivering exceptional customer experiences, nurturing a culture that empowers its people, and ensuring sustainable, profitable growth.
For more information, visit www.malaysiaaviationgroup.com.my
Issued by Group Communications, Malaysia Aviation Group.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Malaysia Airlines Strengthens East Asia Network with Return to Fukuoka, Launch of New Routes and Increased Frequencies Across Key Markets
